New shot takes on deadly brain tumor in early trial
Disease control
Recruiting now
This study tests an injection called JL15003 in 40 adults whose glioblastoma brain tumor has come back after standard treatments. The goal is to see if the drug is safe and can shrink tumors or help people live longer. Participants must have a measurable tumor no larger than 3 cm…
Phase: PHASE1, PHASE2 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC